BECHINI, ANGELA
 Distribuzione geografica
Continente #
EU - Europa 10.670
NA - Nord America 9.369
AS - Asia 2.190
OC - Oceania 75
AF - Africa 64
SA - Sud America 41
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.411
Nazione #
US - Stati Uniti d'America 9.337
PL - Polonia 3.231
RU - Federazione Russa 3.105
IT - Italia 1.675
IE - Irlanda 850
SE - Svezia 736
SG - Singapore 557
CN - Cina 388
HK - Hong Kong 342
IN - India 224
DE - Germania 222
JO - Giordania 176
FI - Finlandia 168
CH - Svizzera 161
GB - Regno Unito 145
TR - Turchia 142
KR - Corea 108
UA - Ucraina 105
AU - Australia 70
VN - Vietnam 68
NL - Olanda 62
CI - Costa d'Avorio 45
FR - Francia 45
ES - Italia 40
TH - Thailandia 38
IR - Iran 33
BR - Brasile 28
BE - Belgio 20
CA - Canada 20
PH - Filippine 20
ID - Indonesia 18
CZ - Repubblica Ceca 16
TW - Taiwan 15
GR - Grecia 14
BG - Bulgaria 11
JP - Giappone 11
AT - Austria 10
LV - Lettonia 10
AR - Argentina 9
SI - Slovenia 8
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
HR - Croazia 6
MX - Messico 6
RO - Romania 6
BH - Bahrain 5
KZ - Kazakistan 5
MY - Malesia 5
PK - Pakistan 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
CY - Cipro 4
EG - Egitto 4
HU - Ungheria 4
IL - Israele 4
SC - Seychelles 4
FJ - Figi 3
NO - Norvegia 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
CL - Cile 2
EU - Europa 2
IS - Islanda 2
KE - Kenya 2
MN - Mongolia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
AL - Albania 1
AN - Antille olandesi 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
CM - Camerun 1
CO - Colombia 1
EE - Estonia 1
HN - Honduras 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
TJ - Tagikistan 1
Totale 22.411
Città #
Warsaw 3.215
Santa Clara 1.983
Fairfield 862
Dublin 845
Chandler 724
Ashburn 464
Singapore 436
Cambridge 371
Seattle 358
Woodbridge 350
Houston 302
Florence 294
Wilmington 281
Princeton 239
Lawrence 210
Altamura 206
Mumbai 191
Jacksonville 180
Beijing 176
Boston 175
Buffalo 171
Ann Arbor 153
Bern 151
Hong Kong 149
Boardman 143
Moscow 135
New York 97
Medford 95
Shanghai 92
San Diego 75
Izmir 71
Kent 69
Rome 62
Milan 60
Dong Ket 56
Los Angeles 54
Abidjan 45
Sydney 42
Bremen 41
Norwalk 41
Dearborn 36
London 29
Hillsboro 28
Munich 28
Bangkok 27
Falls Church 23
Andover 21
Yubileyny 21
Barcelona 20
Seodaemun-gu 20
Genoa 19
Phoenix 18
Helsinki 17
Toronto 17
Naples 16
Seoul 16
Amsterdam 15
Gangnam-gu 15
Melbourne 15
Bari 14
Brussels 14
Catania 14
Pisa 14
Plymouth 14
Roelofarendsveen 14
West Jordan 14
Bologna 13
Pune 13
Redwood City 13
Padova 12
Ancona 11
Palermo 11
Philadelphia 11
Brno 10
Goyang-si 10
Guangzhou 10
Riga 10
Rimini 10
Auburn Hills 9
Bergamo 9
Napoli 9
Perugia 9
Prato 9
Turin 9
Verona 9
Baltimore 8
Brescia 8
Genova 8
Hamburg 8
Olgiate Olona 8
Parma 8
Boadilla del Monte 7
Caserta 7
Chiang Mai 7
Laurel 7
Sassari 7
Sofia 7
Washington 7
Adelaide 6
Anguillara Sabazia 6
Totale 14.469
Nome #
Measuring health literacy in Italy: A validation study of the HLS-EU-Q16 and of the HLS-EU-Q6 in Italian language, conducted in Florence and its surroundings 846
Vaccinazioni e asplenia: quale percorso per il paziente splenectomizzato? 420
HPV vaccination for boys? A systematic review of economic studies 298
Antimeningococcal and antipneumococcal vaccination determinants: A European systematic literature review 264
Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy 260
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis 250
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 246
Human papilloma virus vaccination: impact and recommendations across the world. 235
Primary hepatitis A vaccination failure is a rare although possible event: results of a retrospective study 233
Health literacy in Italy: a cross-sectional study protocol to assess the health literacy level in a population-based sample, and to validate health literacy measures in the Italian language 233
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention 232
Preparing to introduce the varicella vaccine into the Italian immunisation programme: Varicella-related hospitalisations in Tuscany, 2004-2012 231
The epidemiology of mumps in Italy 220
Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants’ vaccination? 219
The epidemiology of Varicella Zoster Virus infection in Italy. 217
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012 215
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? 209
The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries. 200
How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome chapter project 195
Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy 188
Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions 184
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 179
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment 175
Non-familial paid caregivers as potential flu carriers and cause of spread: the primary prevention of flu measured through their adhesion to flu vaccination campaigns—A Florentine experience 174
Raccomandazioni ed evidenze scientifiche a supporto del valore della vaccinazione DTPa-IPV in età prescolare 163
Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries 160
Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign? 160
Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: Results of a semi-quantitative survey 153
How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines 147
Safety and perception: What are the greatest enemies of HPV vaccination programmes? 145
Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades 144
Health literacy as a mediator of the relationship between socioeconomic status and health: A cross-sectional study in a population-based sample in Florence 141
Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy 135
INCREASING RESISTANCE IN COMMENSAL ESCHERICHIA COLI, BOLIVIA AND PERU 134
Recrudescenza di casi di malattia meningococcica invasiva in Toscana e strategie vaccinali adottate dal 2015 134
Progress in Italy in control and elimination of measles and congenital rubella. 131
Recommended vaccinations for asplenic and hyposplenic adult patients 125
Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women. 124
Childhood Vaccination Coverage in Europe: Impact of different Public Health Policies 123
Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. 123
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy 119
Referral of newly diagnosed chronic hepatitis B and C patients in six EU countries: Results of the HEPscreen Project 116
Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. 115
Progress in Italy in control and elimination of measles and congenital rubella. 114
Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening 111
Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project 111
Health literacy and vaccination: A systematic review 110
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations 109
The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment 108
Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy. 106
Focusing on the implementation of 21st century vaccines for adults 104
L’EFFICACIA DEL PROGRAMMA DI VACCINAZIONE UNIVERSALE ANTI-VARICELLA IN TOSCANA: EVIDENZE DI UN OBIETTIVO RAGGIUNGIBILE DEL PNPV. 104
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy 103
Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence 102
Rubella seroprevalence boost in the pediatric and adolescent population of florence (Italy) as a preventive strategy for congenital rubella syndrome (CRS) 102
An overview on the implementation of HPV vaccination in Europe. 102
Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination. 101
Travelers' compliance to prophylactic measures and behavior during stay abroad: results of a retrospective study of subjects returning to a travel medicine center in Italy. 100
Measurement and reporting of burden of disease for hepatitis a: results of the EUROHEP.NET feasibility survey 99
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy. 99
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy) 98
The expected impact of new vaccines and vaccination policies. 96
Awareness of hepatitis B and C screening and patient management guidelines among health professionals in six European countries 96
Utility of healthcare system-based interventions in improving the uptake of influenza vaccination in healthcare workers at long-term care facilities: A systematic review. 96
Gli operatori sanitari degli ospedali fiorentini: protetti o non protetti verso morbillo, parotite, rosolia e varicella? 96
Analisi costo-efficacia della vaccinazione anti-meningococcica con vaccino coniugato quadrivalente ACYW135 in Italia. 95
Valutazione dell’immunità umorale e cellulo-mediata verso Bordetella pertussis in Toscana 94
Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: A meta-analysis of observational studies 93
Epidemiologia storica della rosolia in Toscana e nuovo flusso di notifica obbligatoria 93
Assessment of the clinical and economic impact of different immunization protocols of measles, mumps, rubella and varicella in internationally adopted children 92
Evaluating the costs and benefits of pneumococcal vaccination in adults 92
Immunization with the 7-valent conjugate pneumococcal vaccine: Impact evaluation, continuing surveillance and future perspectives. 91
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 90
Perspectives of public health: present and foreseen impact of vaccination on the epidemiology of hepatitis B 90
Clinical and economic impact of herpes zoster vaccination in elderly in Italy 90
Eliminazione del morbillo: risultati e prospettive nella Regione Toscana 88
Donne in gravidanza e vaccinazioni: impatto di un intervento educativo nel territorio fiorentino 87
Analisi delle reazioni avverse alla prima dose di vaccini antimorbillo e antivaricella in Toscana dal 2011-2014. 87
Hepatitis B: Are at-risk individuals vaccinated if screened and found negative for HBV? Results of an online survey conducted in six EU countries 87
Un caso di studio su una sospetta associazione tra vaccinazione anti-varicella e reazione avversa a vaccino. 87
High chance to overcome the non-responder status to hepatitis B vaccine after a further full vaccination course: results from the extended study on healthcare students and workers in Florence, Italy 87
Discrepancies between vaccine documentation and serologic status for diphtheria, tetanus, and hepatitis b in internationally adopted children 86
Safety and tolerability of bivalent HPV vaccine: An Italian post-licensure study. 86
Epatite B e C: pratiche di counselling e referral in soggetti migranti (progetto HEPSCREEN) 86
The burden of disease of Herpes Zoster in Tuscany 85
An eHealth Project on Invasive Pneumococcal Disease: Comprehensive Evaluation of a Promotional Campaign 85
A cost-benefit analysis of different varicella vaccination strategies involving italian children and adolescents. 85
Valutazione del rischio di morbillo, rosolia e parotite negli operatori sanitari dell’azienda sanitaria di Firenze (ASF) 84
Analisi economica della vaccinazione anti-varicella nei bambini e negli adolescenti italiani: il peso delle ospedalizzazioni senza complicazioni. 83
Hepatitis B seroprevalence in the pediatric and adolescent population of florence (Italy): An update 27 years after the implementation of universal vaccination 83
Measles outbreak in Grosseto, central Italy, 2006. 83
Implementation of the Plan for Elimination of Measles and Congenital Rubella Infection in Tuscany: evidence of progress towards phase II of measles control 82
Le abitudini sessuali e i fattori di rischio per l’infezione da HPV degli studenti toscani. 82
20 anni di vaccinazione anti-epatite B in Italia: una valutazione economica. 81
Immunization status against measles, mumps, rubella and varicella in a large population of internationally adopted children referred to Meyer children’s university hospital from 2009 to 2018 81
Application of socio-economic-health deprivation index, analysis of mortality and influenza vaccination coverage in the elderly population of Tuscany 80
Economic studies applied to vaccines against invasive diseases: An updated budget impact analysis of age-based pneumococcal vaccination strategies in the elderly in Italy 79
The experience of vaccinarsintoscana website and the role of new media in promoting vaccination 78
Progress in the elimination of measles and congenital rubella in Central Italy. 78
Valutazione dell’efficacia del programma di vaccinazione antivaricella in Toscana, nella ASL di Firenze e nella ASL di Prato nel periodo 2009-2013. 78
Totale 13.990
Categoria #
all - tutte 63.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.931 0 0 0 0 290 270 230 313 223 270 280 55
2020/20211.932 158 195 80 201 110 234 96 148 176 308 77 149
2021/20221.452 55 180 82 54 38 38 47 128 40 59 270 461
2022/20234.050 344 616 219 259 250 706 543 235 529 28 134 187
2023/20242.545 88 201 296 177 227 292 195 340 109 228 222 170
2024/20256.894 467 1.277 796 1.816 2.538 0 0 0 0 0 0 0
Totale 22.670